Stockscreener 앱 받기
0.5949
7.58%
0.0419
시간 외 거래:
.60
0.0051
+0.86%
전일 마감가:
$0.553
열려 있는:
$0.5861
하루 거래량:
77,253
Relative Volume:
0.38
시가총액:
$20.74M
수익:
-
순이익/손실:
$-82.19M
주가수익비율:
-0.155
EPS:
-3.839
순현금흐름:
$-8.35M
1주 성능:
+5.85%
1개월 성능:
-16.33%
6개월 성능:
-45.92%
1년 성능:
-3.44%
1일 변동 폭
$0.5541
$0.619
1주일 범위
$0.5329
$0.619
52주 변동 폭
$0.4603
$7.79
Ocean Biomedical Inc Stock (OCEA) Company Profile
명칭
Ocean Biomedical Inc
전화
(646) 908-2658
주소
515 MADISON AVE SUITE 8078, NEW YORK
OCEA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.5949 | 20.74M | 0 | -82.19M | -8.35M | -3.0969 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.76 | 104.50B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.19 | 78.59B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
620.16 | 37.08B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.62 | 30.13B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.30 | 27.64B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ocean Biomedical Inc 주식(OCEA)의 최신 뉴스
Ocean Biomedical Inc Com (OCEA) reports earnings - Quartz
Ocean Biomedical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
Ocean Biomedical stock hits 52-week low at $0.51 - Investing.com
Ocean Biomedical stock hits 52-week low at $0.51 By Investing.com - Investing.com UK
Ocean Biomedical appoints new auditing firm - Investing.com
Ocean Biomedical appoints new auditing firm By Investing.com - Investing.com UK
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily
Ocean Biomedical faces Nasdaq delisting over market value - Investing.com
Ocean Biomedical faces Nasdaq delisting over share price - Investing.com
Ocean Biomedical faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Ocean Biomedical dismisses Deloitte as certifying accountant - Investing.com
Ocean Biomedical dismisses Deloitte as certifying accountant By Investing.com - Investing.com Nigeria
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 16.6% in November - Defense World
Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Mov - GuruFocus.com
Ocean Biomedical faces Nasdaq delisting - Providence Business News
Ocean Biomedical, Inc. Announces Receipt of Notice from - GlobeNewswire
Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com
Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewswire Inc.
Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com
CO2 Energy Transition Corp. Announces Closing of Previously Announced IPO and Full Exercise of Over-allotment - EIN News
BW LPG takes delivery of vessel BW Capella - MSN
Class Action Lawsuit Against Bumble Inc. (NASDAQ:BMBL) - MSN
BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com
Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
Ocean Biomedical appoints interim CEO amid executive shift - Investing.com India
Ocean Biomedical appoints interim CEO amid executive shift By Investing.com - Investing.com South Africa
Ocean Biomedical receives Nasdaq’s delisting letter - MSN
Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services - The Manila Times
Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter - GlobeNewswire
Taipei showcases cutting-edge medical devices & diagnostics at Medica 2024 - healthcare-in-europe.com
Ocean Biomedical secures 22% Virion stake with $9 million deal - Investing.com India
Ocean Biomedical secures 22% Virion stake with $9 million deal By Investing.com - Investing.com South Africa
Molecure inks $32 million deal with Ocean Biomedical for cancer therapy - Investing.com India
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. - The Manila Times
Molecure (WSE: MOC) and Nasdaq-listed biotechnology company - GlobeNewswire
Molecure S.A. and Ocean Biomedical Inc. Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 inhibitors - Marketscreener.com
CAE Inc. (CAE): An Undervalued Foreign Stock to Buy According to Analysts - Yahoo Finance UK
Ocean Biomedical Inc (OCEA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
자본화:
|
볼륨(24시간):